CD43 REGULATION OF IMMUNE RESPONSES
CD43 REGULATION OF IMMUNE RESPONSES
批准号:
6374094
负责人:
Anne I. Sperling
金额:
$27.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2005-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CD43 is unarguably one of the most abundant proteins on the T cell surface. However, the literature is full of seemingly contradictory findings on the function of this molecule. In particular, CD43 has been proposed to function as both a co-stimulatory molecule and a negative regulating molecule. These contradictory hypotheses are based on the observation that cross-linking CD43 and CD43-deficiency have the same net effect. in both situations the T cells have augmented responses to stimulus. Second, we find that when T cells interact with APC, CD43 is naturally excluded from the contact site. Together, these data support the hypothesis that, due its abundance and highly glycosylated nature, CD43 acts as a barrier to T cell interactions. We have found that CD43 associates at least 7 phosphorylated proteins, one of which is a key player in the TCR signal transduction. We believe that understanding 1) the mechanism of CD43 modulation, 2) the proteins that move out of the interaction site due to their association with the cytoplasmic tail of CD43 modulation, 2) the proteins that move out of the interaction site due to their association with the cytoplasmic tail of CD43, and 3) the functional consequences of CD43 modulation, will lead to the elucidation of the role this protein plays in immune regulation. Thus, the central hypothesis of this proposal is that the unique ability of CD43 to move away from the T cell: APC interaction site is the mechanism by which CD43 regulates T cell function. Therefore, the goal of this grant is to identify the molecular interactions T cell immune responses. To achieve these goals, we propose the following specific aims: (1) Determine whether CD43 movement occurs through cytoplasmic interactions with the cytoskeleton. We hypothesize that an inside/out signal from the transfected into a CD43-/- T cells to determine the role of highly charged extra-cellular region of CD43 and the intracellular region in the modulation of CD43 from the T cell-APC interaction site. (2) To elucidate the signal transduction pathways involved in CD43 modulation from the T cell-APC interaction site. We hypothesize that T cell receptor signaling leads to the phosphorylation and modulation of CD43 via the association of intracellular protein intermediates. To test this hypothesize that CD43 influences T cell responses by modulating away from the T cell: APC interaction site and that in dong so, CD43 regulates conjugate formation and specifically removes TCR signal transduction molecules from the site of activation. To test this hypothesis, the effect of CD43 modulation on T cell function will be tested by comparing the functional capacity of wild type, CD43-/-, and CD43-/- cells that have been reconstituted with mutant CD43 molecules that have altered modulating abilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Function of asthma- and allergic disease-associated risk variants and genes in lung immune cells
-
批准号:10261991
-
项目类别:
-
资助金额:$47.46万
-
财政年份:2021
-
负责人:Anne I. Sperling
-
依托单位:
Function of asthma- and allergic disease-associated risk variants and genes in lung immunecells
-
批准号:10827535
-
项目类别:
-
资助金额:$48.04万
-
财政年份:2021
-
负责人:Anne I. Sperling
-
依托单位:
Function of asthma- and allergic disease-associated risk variants and genes in lung immune cells
-
批准号:10453777
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2021
-
负责人:Anne I. Sperling
-
依托单位:
IRF4+ respiratory dendritic cells in type 2 inflammatory responses
-
批准号:9311817
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2017
-
负责人:Anne I. Sperling
-
依托单位:
Human Lung T cell subsets in Disease
-
批准号:9169074
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2016
-
负责人:Anne I. Sperling
-
依托单位:
HLA-G effector mechanisms in asthma
-
批准号:8691382
-
项目类别:
-
资助金额:$6.67万
-
财政年份:2013
-
负责人:Anne I. Sperling
-
依托单位:
Lung Biological Specimens Core
-
批准号:8380132
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2012
-
负责人:Anne I. Sperling
-
依托单位:
HLA-G effector mechanisms in asthma
-
批准号:8380125
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2012
-
负责人:Anne I. Sperling
-
依托单位:
HLA-G effector mechanisms in asthma
-
批准号:8196611
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2011
-
负责人:Anne I. Sperling
-
依托单位:
Dendritic cell produced IL-33 in Th2 responses
-
批准号:8104938
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2011
-
负责人:Anne I. Sperling
-
依托单位:
Lung Biological Specimens Core
-
批准号:8196617
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2011
-
负责人:Anne I. Sperling
-
依托单位:
Dendritic cell produced IL-33 in Th2 responses
-
批准号:8318053
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2011
-
负责人:Anne I. Sperling
-
依托单位:
Mechanisms of Resolution in Experimental Asthma
-
批准号:7879705
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2009
-
负责人:Anne I. Sperling
-
依托单位:
Amnis ImageStream Analyzer
-
批准号:7794015
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2009
-
负责人:Anne I. Sperling
-
依托单位:
CD43 Regulation of Immune Responses
-
批准号:7922800
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2009
-
负责人:Anne I. Sperling
-
依托单位:
BD LSR II Flow Cytometer
-
批准号:7595564
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2009
-
负责人:Anne I. Sperling
-
依托单位:
Immunology Core
-
批准号:7700362
-
项目类别:
-
资助金额:$19.65万
-
财政年份:2008
-
负责人:Anne I. Sperling
-
依托单位:
FLOW CYTOMETRY
-
批准号:7714277
-
项目类别:
-
资助金额:$10.4万
-
财政年份:2008
-
负责人:Anne I. Sperling
-
依托单位:
FITCH MONOCLONAL ANTIBODY
-
批准号:7714274
-
项目类别:
-
资助金额:$4.98万
-
财政年份:2008
-
负责人:Anne I. Sperling
-
依托单位:
Mechanisms of Resolution in Experimental Asthma
-
批准号:8037131
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2007
-
负责人:Anne I. Sperling
-
依托单位:
海外基金